mRNA-1273.222
- Generic Name
- mRNA-1273.222
Moderna Faces Scrutiny Over Incentives in Pediatric COVID-19 Vaccine Trial
• Moderna is under scrutiny after a UK NHS pediatrician offered children £1,500 to participate in the Phase III NextCOVE COVID-19 vaccine trial.
• The Prescription Medicines Code of Practice Authority (PMCPA) found Moderna in breach of conduct for failing to maintain high standards.
• The incentive contravened clinical trial regulations prohibiting financial inducements to children, potentially undermining informed consent.
• Moderna stated that the amount was from a draft document and that participants only received compensation for travel expenses.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath